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Ultrafiltration and solute kinetics using low sodium peritoneal dialy.
sate. Low sodium peritoneal dialysate has been reported to enhance
sodium loss and alleviate signs of fluid overload in continuous ambulatory
peritoneal dialysis patients. To elucidate the mechanisms involved, we
compared ultrafiltration and solute kinetics using low sodium dialysate
(LNaD; 105 mEq/liter sodium, 2.5% glucose, 348 mOsm/liter), conven-
tional dialysate with equal osmolality (CD 1.5; 132 mEq/liter sodium, 1.5%
glucose, 348 mOsm/liter) and conventional dialysate with equal glucose
concentration (CD2.5; 132 mEq/liter sodium, 2.5% glucose, 403 mOsm/
liter). A 2 liter, six hour exchange of each dialysate was pcrformcd on
separate days in 10 chronic peritoneal dialysis patients. Transperitoneal
solute diffusion was assessed by calculating the permeability-area product
(PA) of the peritoneal membrane from the dependence of plasma and
dialysate solute concentrations on time. Net fluid removed using LNaD of
190 90 (sEM) ml was similar to that using CD2.5 (250 90 ml) but
higher (P < 0.01) than that using CD1.5 (—200 60 ml). Sodium loss was
higher using LNaD (72 11 mEq, P < 0.01) and CD2.5 (41 12 mEq,
P < 0.05) than using CD1.5 (—18 8 mEq). Changes in plasma sodium
concentration were small during each dwell and were not different among
the study dialysates. PA values for urea (23.4 1.6 mI/mm), creatinine
(10.0 1.0 mi/mm), and glucose (10.3 1,3 mI/mm) were similar when
determined in each dialysate. The PA value for sodium (7.6 1.5 mI/mm)
could only be accurately determined in LNaD. We conclude that: (1) net
fluid removed is greater using LNaD than CD1.5 despite similar osmola-
lities because LNaD has a higher glucose concentration and glucose is a
more effective osmotic solute than sodium; (2) sodium loss when using
LNaD is enhanced by both diffusion and convection; and (3) sodium
diffuses across the peritoneum slower than urea, creatininc and glucose.
These data suggest that LNaD alleviates signs of fluid overload by
increasing net fluid removal and enhancing sodium loss.
The composition of solutions employed during peritoneal dial-
ysis are designed primarily to remove water and uremic toxins
from (and to deliver base to) end-stage renal disease patients.
While numerous studies have previously determined the relation-
ship between the transperitoneal ultrafiltration rate and the
concentration of different osmotic solutes [1], the optimal sodium
concentration for dialysis solutions has not been extensively
investigated. Commercial peritoneal dialysate originally contained
140.5 mEq/liter of sodium [21; however, hypernatremia could
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occur during intermittent peritoneal dialysis when frequent hy-
pertonic exchanges containing this sodium concentration were
used [3, 4]. Subsequent studies [5, 6] demonstrated that dialysates
containing lower sodium concentrations resulted in enhanced
sodium removal from the patient and would therefore likely
lessen the possibility of hypernatremia. Thus, commercial dialy-
sates presently contain 132 mEq/liter of sodium.
Certain investigators have recently suggested that lowering the
sodium concentration of peritoneal dialysate may be advanta-
geous in certain patients. In preliminary studies Nakayama et al
[7, 8] demonstrated that the use of one or two exchanges per day
of dialysate containing a low sodium concentration (98 mEq/liter)
resulted in increased sodium and fluid removal, decreased patient
body wt (and presumably body water), and decreased blood
pressure in overhydrated patients undergoing continuous ambu-
latory peritoneal dialysis (CAPD). The low sodium concentration
in the dialysate enhanced sodium removal from the patient
presumably by increasing the concentration difference of sodium
across the peritoneal membrane, but the mechanisms resulting in
increased fluid removal were not investigated. More recently,
Imholz et al [9] have compared ultrafiltration and solute kinetics
during exchanges containing conventional sodium (132 mEq/liter)
and low sodium (102 mEq/liter) dialysates with similar osmolali-
ties of approximately 380 mOsm/liter. These investigators ob-
served that the low sodium dialysate increased transperitoneal
ultrafiltration without altering the transport properties of the
peritoneal membrane and suggested, based on calculations from a
mathematical model, that enhanced ultrafiltration was the result
of the higher effective osmotic pressure in the low sodium
dialysate.
For the low sodium dialysates studied to date, a higher glucose
concentration has been employed to maintain a solution osmola-
lity equal to that for conventional dialysates; thus, these solutions
have both a low sodium concentration and a high glucose concen-
tration. To evaluate the effects of a low sodium concentration
separately from those due to a high glucose concentration, we
have compared ultrafiltration and solute kinetics in a peritoneal
dialysate that contained low sodium concentration with two
commercial dialysates that were equal in either osmolality or
glucose concentration. Our results confirm and extend the find-
ings of Imhoiz et al [9] and further demonstrate that enhanced
transperitoneal ultrafiltration when using a low sodium peritoneal
dialysate is primarily due to its high glucose concentration.
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Table 1. Composition of study dialysates
Solute CD 1.5 CD2.5 LNaD
Sodium mEqiliter 132 132 105
Chloride mEqiliter 96 96 69
Glucose g% 1.5 2.5 2.5
Magnesium mEqiliter 0.5 0.5 0.5
Calcium mEq/liter 3.5 3.5 3.5
Lactate mEq/liter 40 40 40
Calculated osmolality mOsm/liter 348 408 348
Methods
Solutions
This study was designed to compare ultrafiltration and solute
kinetics in three different peritoneal dialysates that differed in
sodium (and chloride) concentration, glucose concentration, or
osmolality (Table 1). Low sodium dialysate (LNaD) was prepared
by the Pharmacy Department at the University of Utah Medical
Center using sterile techniques. LNaD had a higher glucose
concentration but the same calculated osmolality (348 mOsm/
liter) as commercial dialysate with 1.5% glucose (CD1.5: Dianeal
1.5%; Baxter Healthcare, McGaw Park, Illinois, USA). LNaD had
the same glucose concentration but a lower calculated osmolality
than commercial dialysate with 2.5% glucose (CD2.5: Dianeal
2.5%; Baxter). Both commercial dialysates had a sodium concen-
tration of 132 mEq/liter.
Patients
Chronic peritoneal dialysis patients were recruited from the
University of Utah Dialysis Program. Exclusion criteria for par-
ticipation in the study were (1) patients under 21 or over 80 years
of age; (2) terminally ill patients; (3) patients who had peritonitis
within a month prior to enrollment or those with a history of
recurrent peritonitis; (4) patients with a serum sodium concentra-
tion less than 120 mEq/liter; 5) patients with congestive heart
failure (NYHA Class III or IV); (6) patients with known hyper-
sensitivity to penicillin or neutral dextran; and (7) pregnant
women or prisoners. The study protocol was approved by the
Institutional Review Board at the University of Utah, and written
informed consent was obtained from eleven patients. Ten patients
completed the study; the remaining patient was dropped from the
study because of an extended hospitalization stay.
Mean patient age was 44 years (range 26 to 65). Five patients
were male, and five were female. Nine patients were Caucasians,
and one was a Native American. Four patients were diabetic. Nine
patients were maintained on routine CAPD using four exchanges
per day, and one was maintained on nighttime intermittent
peritoneal dialysis. Routine peritoneal equilibration tests [10]
indicated that peritoneal membrane permeability for each patient
was either in the low average or high average category. Each
patient was studied three times on separate days, once with each
dialysate. The study was completed within one month for eight
patients and within two months for two patients. The order of the
solutions was randomly allocated to each patient using random
sampling numbers [11].
Protocol
The patients were instructed to perform their overnight dwell
using Dianeal 2.5% and arrive at the dialysis unit prior to draining
their overnight exchange. A standardized breakfast was provided;
then, the overnight dwell was drained for 20 minutes. Six millili-
ters of 30% dextran 70 solution (Kendall McGaw, Irvine, CA,
USA) were added to each 2 liter dialysate bag as a volume marker,
and the dialysate was warmed before it was infused into the
peritoneal cavity. Three ml samples were taken from the perito-
neal cavity 3, 15, 30, 60, 90, 120, 180, 240, and 360 minutes after
infusion of the dialysate was complete. These samples were
collected after draining approximately 100 ml of dialysate from
the peritoneal cavity; the latter was immediately returned to the
peritoneal cavity after sampling. Three milliliter blood samples
were also taken 0, 30, 60, 90, 120, 180, and 360 minutes after
infusion of the dialysate was complete. Access to peripheral blood
was difficult in four patients; therefore, blood samples were only
taken at 0, 180, and 360 minutes in these patients. All blood
samples were allowed to clot at room temperature and then
centrifuged. Chemical analysis was performed on the serum
(denoted subsequently as plasma to conform to convention)
fraction. After taking the samples at 360 minutes, the peritoneal
cavity was drained for 20 minutes (drained volume) and 1 liter of
Dianeal 1.5% was infused into the peritoneal cavity for determi-
nation of residual volume using the indicator dilution technique.
A 3 ml sample of the solution in the peritoneal cavity was taken
five minutes after the infusion was complete. The patients then
resumed their routine dialysis treatment schedule.
Analytical
Volumes infused and drained were measured by weighing each
bag, both empty and full, to the nearest 10 g. Weights were
converted to volumes by assuming a fluid density of 1 gIml.
Sodium, chloride, urea, creatinine, glucose and total protein
concentrations were measured using an automated analyzer
(Beckman CX-5 and CX-7; Brea, CA, USA). The Beckman CX
systems measure sodium and choride activities using ion selective
electrodes; these values are reported as concentrations. Since
creatinine assays are also sensitive to glucose, creatinine concen-
trations uncorrected for high glucose concentration are falsely
high. Thus, all creatinine dialysate concentrations in this study
were corrected for glucose concentrations using the following
relationship between interference creatinine concentration in
mg/dl (Cr) and glucose concentration in g/dl (G) determined in
our laboratory as
Cr = 0.186 G + 0.115
Total solution osmolality was measured using a vapor pressure
osmometer (Model 5500; Wescor, Logan, Utah, USA).
Dextran 70 in peritoneal dialysate was resolved into component
molecular weight distributions using high performance liquid
chromatography as described previously [12, 131 except that a
TSK-G4000PW column (Kratos Analytical, Ramsey, NJ, USA)
was used. The concentration of dextran 70 was assessed by the
area under the chromatogram.
Calculations
Indicator dilution estimates of dialysate volume were first
calculated as a function of dwell time using the indicator dilution
technique assuming no dextran 70 was lost from the peritoneal
cavity [13]. These indicator dilution estimates of dialysate volume
overestimate the true volume of the solution within the peritoneal
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Table 2. Measured volumes at the start and the end of the
study exchange
Volume liter CD1.5 CD2.5 LNaD
Instilled 2.12 0.02' 2.12 0.01k' 2.06 0.01
Drained 1.92 0.06a 2.37 0.09 2.25 0.10
Residual (Start) 0.17 0.07 0.20 0.07 0.19 0.09
Residual (end) 0.46 0.12 0.29 0.05 0.39 0.15
Fluid removed —0.20 0•06h 0.25 0.09 0.19 0.09
cavity because some dextran 70 was lost from the peritoneal cavity
[14]. Nevertheless, volumes determined by the indicator dilution
technique are the best available for calculating solute transport
parameters of the peritoneum during peritoneal dialysis [15].
Residual volume at the start of each exchange was calculated by
the change in the concentration of dextran 70 in the infused
solution and that after three minutes of dwell. Residual volume at
the end of each exchange was calculated from the change in
concentration of dextran 70 in the drained effluent and the rinse
fluid (1 liter of Dianeal 1.5%, see above) after the fluid within the
peritoneal cavity was allowed to mix for five minutes. The average
fluid loss rate from the peritoneal cavity into the lymphatics and
adjacent interstitial tissues for the entire exchange was calculated
as dialysate volume determined by the indicator dilution tech-
nique at the end of the exchange minus the residual volume at the
end of the exchange minus the drained volume divided by dwell
time [16]. True values of dialysate volume were then calculated by
subtracting the average fluid loss rate times the dwell time from
the indicator dilution estimates of dialysate volume. Ultrafiltra-
tion over the time interval of interest was calculated as the final
dialysate volume determined by the indicator dilution technique
minus the initial dialysate volume determined by the indicator
dilution technique. Net fluid removed was calculated as the
drained volume minus the instilled volume.
Sodium or protein loss from the patient was calculated as the
mass of sodium or protein drained (volume times concentration)
minus the mass instilled, and glucose absorbed was calculated as
the mass of glucose instilled (volume times concentration) minus
the mass drained.
To calculate peritoneal solute transport parameters, the pen-
toneum was modeled as a membrane separating blood and
peritoneal dialysate as previously described [13, 15]. Data analysis
was performed in two ways. First, it was assumed that diffusion
was the only mode of solute transport across the peritoneal
membrane (that is, convective solute transport was neglected).
Values of PA, the permeability-area product (or mass transfer
area coefficient) for the peritoneal membrane, were estimated by
fitting a mathematical model to the time dependence of the
dialysate solute concentration using nonlinear regression with PA as
the adjustable parameter [13]. During exchanges using CD2.5 and
LNaD, where convective solute transport may not be negligible, an
alternative approach was used for characterizing peritoneal solute
transport (except for glucose, see below). In this case, values of PA
and a-, the solvent drag reflection coefficient [1], were estimated by
fitting a mathematical model to the time dependence of the dialysate
solute concentration using nonlinear regression with both PA and a-
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as adjustable parameters [13]. All parameters were estimated using
plasma (not plasma water) solute concentrations.
Statistics
All experimental and calculated parameters are expressed as
mean SEM. The significance of differences between the study
dialysates was compared using repeated measures analysis of
variance [17]. Individual differences were further analyzed using a
paired Student's t-test with modified confidence limits calculated
by the Dunn-Sidák method [18]. Differences were considered
significant at the 0.05 level.
Results
Measured initial osmolality of LNaD (330 2 mOsm/kg H20)
was not different from that for CDI.5 (324 2 mOsm/kg H20)
but was lower (P < 0.01) than that for CD2.5 (377 3 mOsm/kg
H20). All solutions were well tolerated by the patients; no adverse
reactions were observed. Moreover, no patient suffered from
peritonitis while participating in the study. Measured volumes for
the study dialysates are summarized in Table 2. Instilled volumes
were higher for CDI.5 (P < 0.01) and CD2.5 (P < 0.01) than that
for LNaD since commercial bags of dialysate are more overfilled.
Drained volume for LNaD was not different from that for CD2.5
but was higher (P < 0.05) than that for CD1.5. Residual volumes
at the start and end of the exchanges were not different among the
study dialyates. Net fluid removed for LNaD was not different
from that for CD2.5 but was higher (P < 0.01) than that for CD1.5
(see also Fig. 1).
Figure 2 shows the change in true dialysate volume as a function
of dwell time for the study dialysates. Although calculated values
of dialysate volume throughout the dwell appeared to be higher
for CD2.5 than for LNaD and CD1.5, values for LNaD were not
statistically different from those for either CD2.5 or CD1.5, except
at 120 minutes when dialysate volume for LNaD was lower (P <
0.01) than that for CD2.5. Analysis of ultrafiltration over 120
400
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Fig. 1. Net fluid removed, calculated as drained volume minus instilled
volume for a commercial dialysate with the same osmolalily (CD1.5) and a
commercial dialysate with the same glucose concentration (CD2.5) as a low
sodium dialysate (LNaD). Net ultrafiltration volume was higher using
CD2.5 (*P < 0.05) and LNaD (**P < 0.01) than using CD1.5.
CD1 .5 CD2.5 LNaD
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Fig. 2. True dialysate volumes plotted versus dwell time for a commercial
dialysate with the same osmolalily (CDL5, •) and a commercial dialysate
with the same glucose concentration (CD2.5, •) as a low sodium dialysate
(LNaD, A). Calculated volumes for LNaD were not different from those
for either CD1.5 or CD2.5 except at 120 minutes where the calculated
volume for CD2.5 was higher (**P < 0.01) than that for LNaD.
Fig. 3. Ultrafiltration between 0 and 120 minutes, between 120 and 240
minutes and between 240 and 360 minutes for a commercial dialysate with
the same osmolality (CDI.5, •) and a commercial dialysate with the same
glucose concentration (CD2.5, LI) as a low sodium dialysate (LNaD, ).
Cumulative ultrafiltration between 0 and 120 minutes was lower for CD1.5
(*P < 0.05) and LNaD (**P < 0.01) than that for CD2.5. In contrast,
there were no differences among the three study dialysates in ultrafiltra-
tion between 120 and 240 minutes or between 240 and 360 minutes.
minute intervals suggests similar conclusions (Fig. 3). Ultrafiltra-
tion occurred predominantly during the first 120 minutes in each
dialysate, and ultrafiltration during the first 120 minutes was
higher for CD2.5 than LNaD (P < 0.01) or CD1.5 (P < 0.05).
Ultrafiltration between 120 and 240 minutes and between 240 and
360 minutes was higher for LNaD than CD1.5 and CD2.5, but
these differences were not statistically significant. Fluid loss rates
from the peritoneal cavity via lymphatic drainage [19] or direct
absorption into tissues surrounding the peritoneal cavity [20] were
variable and not different among the study dialysates: CD1.5 (0.63
0.42 mi/mm), CD2.5 (0.89 0.61 mI/mm) and LNaD (1.25
0.77 mI/mm). These results are similar to previously reported
rates of fluid absorption from the peritoneal cavity (or rates of
effective lymphatic absorption) [9, 16, 21].
The initial plasma sodium concentration was not different
among the three groups. Plasma sodium concentration decreased
during the six hour dwell by 1.7 0.8 mEq/liter using CD1.5, 0.9
0.5 mEq/liter using CD2.5, and 2.3 1.1 mEqlliter using
LNaD, but these decreases were not statistically significant (0.05
< P < 0.10). Figure 4 compares net sodium loss for the study
dialysates. Sodium loss for LNaD (72 11 mEq) was higher than
that for CD2.5 (41 12 mEq), but this difference was not
significant. Sodium loss for both LNaD (P < 0.01) and CD2.5
(P < 0.05) was higher than that for CD1.5 (—18 8 mEq).
Total plasma protein concentration at the beginning and end of
the dwell was similar for each dialysate (6.0 0.2 and 5.9 0.3
g/dl for CD1.5; 5.8 0.3 and 5.8 0.3 g/dl for CD2.5; and 5.7
0.3 g/dl and 5.8 0.3 g/dl for LNaD, beginning and end,
respectively). Protein loss for CD2.5 (2.1 0.3 g) was higher than
that for both CD1.5 (1.6 0.2 g, P < 0.01) and for LNaD (1.7
0.2 g, P < 0.05). The amount of glucose absorbed was similar for
LNaD (33 2 g) and CD2.5 (35 2 g); both these values were
higher (P < 0.01) than that for CD1.5 (21 1 g).
Figures 5 and 6 show the dependence of the dialysate to plasma
concentration ratio (DIP) forurea on time and the dependence of
the dialysate glucose concentration on time, respectively. Values
of D/P for urea increased during the dwell and were virtually
identical in each study dialysate. Similar results were obtained for
creatinine D/P (data not shown). Dialysate glucose concentration
decreased steadily in all study dialysates, with the concentration in
CD1.5 consistently lower than the corresponding values in LNaD
and CD2.5 as expected. Figure 7 shows the dependence of D/P for
sodium on time in the study dialysates. During exchanges using
either CD1.5 and CD2.5, D/P for sodium did not change signifi-
cantly with dwell time. During the exchange with LNaD, DIP for
sodium was initially less than one as expected and increased
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Fig. 4. Sodium loss, calculated as total mass of sodium instilled minus that
drained, for a commercial dialysate with the same osmolality (CDJ.5) and a
commercial dialysate with the same glucose concentration (CD2.5) as a low
sodium dialysate (LNaD). Sodium loss was higher using CD2.5 (*P < 0.05)
and LNaD (**P < 0.01) than using CD1.5.
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throughout the dwell. The dependence of D/P for chloride on
time paralleled closely that for sodium (data not shown).
Table 3 shows the values of PA calculated from the dependence
0 100 200 300 400
Solute CD1.5 CD2.5 LNaD
Urea 21.0 1.8 25.6 1.4 23.7 3.0
Creatinine 9.5 1.1 10.6 1.3 10.0 1.4
Glucose 10.0 1.7 11.2 1.0 9.4 2.0
Sodium ND ND 7.6 1.5
Chloride ND ND 8.3 4.4
of plasma and dialysate solute concentrations on time. Values of
PA were calculated neglecting convective solute transport in
CD1.5 for all solutes and in all study dialysates for glucose. Values
of PA and cr were simulataneously calculated in CD2.5 and LNaD
for all solutes except glucose. PA values for sodium and chloride
could not be accurately determined in either CD 1.5 or CD2.5
since the solute concentration difference across the peritoneum
was small. PA values were not dependent on the composition of
the dialysate. The mean values (averaged over all study dialysates)
were 23.4 1.6 mI/mm for urea, 10.0 1.0 mI/mm for creatinine
400 and 10.3 1.3 mI/mm for glucose.Table 4 shows the calculated values of the solvent drag reflec-
tion coefficient (or) for urea, creatinine, sodium and chloride in
CD2.5 and LNaD. Values of cr for all solutes could not be
accurately computed in CD 1.5 since little transperitoneal ultrafil-
tration occurs during this exchange (Fig. 2) nor for glucose in all
study dialysates, because solute transport was in the dialysate to
blood direction [22, 23]. Calculated cr values were not different in
CD2.5 and LNaD. Mean values (average of CD2.5 and LNaD)
were 0.27 0.06 for urea, 0.37 0.06 for creatinine, 0.10 0.02
for sodium and 0.06 0.08 for chloride.
Since the composition of the study dialysates was identical
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Fig. 5. Dialysatelplasma concentration ratio (DIP) for urea plotted versus
dwell time for a commercial dialysate with the same osmolalily (CDI.5, •)
and a commercial dialysate with the same glucose concentration (CD2.5, U)
as a low sodium dialysate (LNaD, A).
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Fig. 6. Dialysate concentration of glucose plotted versus dwell time for a
commercial dialysate with the same osmolality (CDJ.5, •) and a commercial
dialysate with the same glucose concentration (CD2.5, U) as a low sodium
dialysate (LNaD, A).
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Fig. 7. Dialysate/plasma concentration ratio (DIP) for sodium plotted versus
dwell time for a commercial dialysate with the same osmolalisy (CD1.5, •)
and a commercial dialysate with the same glucose concentration (CD2. 5, U)
as a low sodium dialysate (LNaD, A).
Table 3. Calculated permeability-area products, mllmin
Data are N = 10 each, mean SEM. ND indicates not determined.
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Ultrafitration kinetics
If the various solutes in different peritoneal dialysis solutions
are equally effective at inducing transperitoneal ultrafiltration
across the peritoneal membrane, dialysates of equal osmolality
throughout the entire dwell will remove equal amounts of fluid. If,
on the contrary, the various solutes in different peritoneal dialysis
solutions are not equally effective at inducing transperitoneal
ultrafiltration, dialysates of equal osmolality may remove unequal
amounts of fluid. The results of the present study demonstrate
that LNaD and CD1.5 have equal total osmolality throughout the
entire dwell (Fig. 8), yet the amount of fluid removed using LNaD
was higher than that using CD1.5 during the six hour exchange
(Fig. 1). LNaD differs from CD1.5 in having lower sodium and
chloride concentrations and a higher glucose concentration.
Therefore, these results demonstrate that glucose is more effec-
tive at inducing transperitoneal ultrafiltration across the perito-
neal membrane than are sodium and chloride. Furthermore, the
amount of fluid removed during the six hour exchange using
LNaD and CD2.5 were not different (Fig. 1). These two dialysates
have the same glucose concentration but different osmolalities
and sodium and chloride concentrations. Therefore, these latter
results suggest that the glucose concentration of the dialysate is
the primary determinant of transperitoneal ultrafiltration or fluid
removal during the entire six hour dwell within the confines of the
dialysates studied (sodium concentrations between 105 and 132
mEq/liter, glucose concentrations between 1.5 and 2.5% and total
calculated osmolalities between 348 and 408 mOsm/liter).
The present observations regarding the relative importance of
glucose and sodium chloride to induce transperitoneal ultrafiltra-
tion are consistent with previous theoretical analyses and experi-
mental studies in animals. For example, Rippe, Perry and Granger
[24] empirically determined osmotic reflection coefficients, a
measure of the ability of osmotic solutes to induce transperitoneal
ultrafiltration, for the cat peritoneal membrane. The osmotic
Dwell time, minutes
Fig. 8. The sum of sodium, chloride, and glucose concentration differences
across the peritoneum (dialysate minus plasma) plotted versus dwell time for
a commercial dialysate with the same osmolalily (CD1.5, •) and a commer-
cial dialysate with the same glucose concentration (CD2.5, U) as a low
sodium dialysate (LNaD, A). The sum of sodium, chloride, and glucose
concentration differences was higher for CD2.5 (P < 0.01) than that for
CD 1.5 and LNaD at all times except at 240 and 360 minutes.
reflection coefficient for glucose measured in that study was
approximately 70% greater than that for sodium chloride. Chen
and coworkers [25], based on experiments using 5% glucose
solutions (in the absence of sodium chloride) as dialysate in rats,
have reported that the osmotic reflection coefficient for glucose
(0.32) was approximately 20% higher than that for sodium (0.27).
Last, Vonesh and Rippe [26] calculated that the osmotic reflec-
tion coefficient for glucose (0.0430) must be approximately 65%
higher than that for sodium (0.0262) to obtain good agreement
between empirically determined dialysate volume profiles in
CAPD patients and a pore-containing membrane model of the
peritoneum.
Imholz and coworkers [9] have recently determined the depen-
dence of dialysate volume and osmolality on dwell time in a low
sodium dialysate and in a commercial dialysate of approximately
equal initial osmolality (380 mOsm/kg H20) in CAPD patients.
They observed that transperitoneal ultrafiltration was similar in
the two dialysates for the first four hours of the dwell, but was
higher during the last two hours in the low sodium dialysate. The
osmolality of the low sodium dialysate was, however, higher than
the osmolality of the commercial dialysate throughout the entire
dwell. These investigators suggested, based on calculations from a
mathematical model, that enhanced transperitoneal ultrafiltration
and fluid removal using the low sodium dialysate was due to its
higher effective osmotic pressure in the dialysate. In their study,
however, the higher effective osmotic pressure of the low sodium
dialysate was attributed predominantly to its higher osmolality
since they estimated that the osmotic reflection coefficients for
glucose and sodium were similar (different by less than 10%). The
results from the present study demonstrate, however, that it is not
necessary to have higher dialysate osmolality in low sodium
dialysates to induce significantly more transperitoneal ultrafiltra-
tion (Figs. 1 and 8). Instead, the specific solutes that make up the
Table 4. Calculated solvent drag reflection coefficients
Solute CD2.5 LNaD
Urea 0.26 0.07 0.28 0.06
Creatinine 0.36 0.07 0.38 0.07
Glucose ND ND
Sodium 0.10 0.03 0.11 0.02
Chloride 0.10 0.09 0.02 0.06
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Data are N = 10 each, mean SEM. ND indicates not determined.
except for their concentrations of sodium, chloride, and glucose
(Table 1), differences in the osmotic pressure driving force for
transperitoneal ultrafiltration among these solutions is a function
of differences in sodium, chloride, and glucose concentrations and
the osmotic reflection coefficients for the individual solutes across
the peritoneum [1]. Figure 8 shows the sum of the concentration
differences (dialysate minus plasma) across the peritoneum for
sodium, chloride, and glucose as a function of time in each study
dialysate. The sum of these concentration differences was higher
(P < 0.01) for CD2.5 than for CDI.5 and LNaD except at 240 and
360 minutes; those for CD1.5 and LNaD were not different from
each other throughout the entire dwell. Direct measurements of
total dialysate osmolality gave similar results (data not shown).
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dialysates and the ability of those solutes to induce osmotic force
play the major roles in governing transperitoneal ultrafiltration.
Solute kinetics
With the possible exception of sodium and chloride, the depen-
dence of dialysate solute concentrations on time in all study
dialysates was as expected. Peritoneal solute transport parameters
(PA and a-) for urea, creatinine and glucose were not different
among the study dialysates. The values of PA for these solutes are
comparable to those reported previously by others for the human
peritoneum [16, 27, 28], and the calculated values of the perito-
neal solvent drag reflection coefficient for urea and creatinine are
also similar to those reported by others [1]. Thus, peritoneal
solute transport parameters determined in low sodium dialysate
are not different from those in commercial dialysates with con-
ventional sodium concentrations. In all instances, urea diffuses
more readily than creatinine and glucose.
Diffusion of sodium and chloride across the human peritoneal
membrane has not been extensively studied, largely because
quantification of diffusion is difficult in commercial dialysates
where dialysate solute concentrations are very similar to those in
patient plasma. Previous studies in animals [29, 30] and humans
[21 using a dialysate of 5% dextrose in the absence of sodium
chloride have suggested that sodium and chloride diffusion across
the peritoneal membrane was as rapid as that for urea. On the
contrary, Waniewski and coworkers [31] have reported mass
transfer area coefficients for sodium that are considerably lower
than those for urea based on an analysis of the dependence of
dialysate sodium concentration on time using a commercial
hypertonic dialysate containing 4.25% glucose concentration. The
results of the present study demonstrate that sodium diffusion
across the peritoneal membrane in a low sodium dialysate is
considerably slower than that for urea, creatinine, and glucose.
Imholz and coworkers [9] have also determined mass transfer area
coefficients for sodium and chloride in a low sodium dialysate that
are similar to those reported herein.
Reported values of the solvent drag reflection coefficient for
sodium and chloride across the human peritoneum are also
limited. (Note that the solvent drag reflection coefficient is likely
different from the osmotic reflection coefficient for the peritoneal
membrane [1].) Waniewski and coworkers [31] have determined
solvent drag reflection coefficients for sodium in commercial
hypertonic solutions (containing 132 mEq/liter of sodium) from
the dependence of dialysate sodium concentration on time. The
value of 0.42 0.10 (SD) reported by these workers was compa-
rable to sodium sieving coefficients previously reported by others
[3, 32], and would suggest that convection of sodium across the
peritoneum is rather severely restricted. The value of the solvent
drag reflection coefficient for sodium and chloride reported in the
present study (Table 4) is, however, considerably lower that that
reported by Waniewski and coworkers.
While the transport parameters for sodium and chloride re-
ported in the present study are not entirely consistent with
previous observations, it is important to note that the transport of
electrolytes may be nonlinear and not as easy to interpret as that
of neutral, noninteracting solutes [33]. For example, Imholz and
coworkers have hypothesized that sodium and chloride diffuse
more slowly across the peritoneum than urea because the inter-
action of these ions with water may alter their transport charac-
teristics. While this hypothesis may be correct, diffusion coeffi-
cients for these ions and urea are very similar in free solution [33]
where their hydration status should be similar to that during
transport across the peritoneal membrane. Furthermore, diffusion
and convection of a negative or a positive electrolyte cannot be
rigorously considered individually as treated herein and in all
previous studies regarding transperitoneal transport of electro-
lytes. Transport of single electrolytes across the peritoneal mem-
brane does not occur; rather, transport of negative and positive
ions must occur together [33]. Indeed, the similar PA values
calculated for sodium and chloride in the present study suggest
that sodium and chloride may transport as ion pairs. Further work
describing transperitoneal transport of electrolytes is likely nec-
essary to resolve the present observations with those previously
reported.
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